Change in HER2 (ERBB2) gene status after taxane-based chemotherapy for breast cancer: polyploidization can lead to diagnostic pitfalls with potential impact for clinical management
- PMID: 23313108
- DOI: 10.1016/j.cancergen.2012.12.001
Change in HER2 (ERBB2) gene status after taxane-based chemotherapy for breast cancer: polyploidization can lead to diagnostic pitfalls with potential impact for clinical management
Abstract
The status of the HER2 (ERBB2) gene in breast cancer is not static and may change among the primary tumor, lymph node metastases, and distant metastases. This status change can be a consequence of the natural evolution of the tumor or can be induced by therapy. The HER2 gene status is, in the majority of cases, established at the moment of diagnosis. After chemotherapy, monitoring HER2 status can be a challenge because of ploidy changes induced by drugs. The cytogeneticist or the pathologist can face real difficulties in distinguishing between a true HER2 amplification and HER2 copy number increase by polyploidization. We performed a HER2 genetic examination by fluorescence in situ hybridization (FISH) of invasive breast cancers before and after taxane treatment. The majority of patients (91%) were HER2-negative both at diagnosis and after treatment. Thirty of 344 patients (9%) whose tumors were initially HER2-negative were found by FISH to have supernumerary HER2 gene copies (up to 15 copies) after neoadjuvant chemotherapy. This HER2 copy increase could not be attributed to true gene amplifications and instead reflected polyploidization events, which presumably affected all chromosomes. Indeed, when we used other FISH probes, we found other gene copy numbers to parallel those of HER2. We recommend careful checking of invasive breast carcinomas by supplementary FISH probes if the copy number of the HER2 gene is >6. This procedure allows the discrimination of specific HER2 gene amplifications and global increases in ploidy.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Influence of neoadjuvant chemotherapy on HER2/neu status in invasive breast cancer.Clin Breast Cancer. 2013 Feb;13(1):53-60. doi: 10.1016/j.clbc.2012.09.011. Epub 2012 Oct 26. Clin Breast Cancer. 2013. PMID: 23103368
-
Determining true HER2 gene status in breast cancers with polysomy by using alternative chromosome 17 reference genes: implications for anti-HER2 targeted therapy.J Clin Oncol. 2011 Nov 1;29(31):4168-74. doi: 10.1200/JCO.2011.36.0107. Epub 2011 Sep 26. J Clin Oncol. 2011. PMID: 21947821
-
Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.Breast Cancer Res Treat. 2003 Dec;82(3):207-13. doi: 10.1023/B:BREA.0000004378.15859.51. Breast Cancer Res Treat. 2003. PMID: 14703068
-
[Diagnosis of HER2 gene amplification in breast carcinoma].Pathol Biol (Paris). 2008 Sep;56(6):375-9. doi: 10.1016/j.patbio.2008.03.009. Epub 2008 May 5. Pathol Biol (Paris). 2008. PMID: 18456424 Review. French.
-
DNA amplifications in breast cancer: genotypic-phenotypic correlations.Future Oncol. 2010 Jun;6(6):967-84. doi: 10.2217/fon.10.56. Future Oncol. 2010. PMID: 20528234 Review.
Cited by
-
Changes in breast cancer grade from biopsy to excision following surgery or primary chemotherapy.Pathologica. 2024 Feb;116(1):22-31. doi: 10.32074/1591-951X-958. Pathologica. 2024. PMID: 38482672 Free PMC article.
-
The antagonistic relationship between apoptosis and polyploidy in development and cancer.Semin Cell Dev Biol. 2024 Mar 15;156:35-43. doi: 10.1016/j.semcdb.2023.05.009. Epub 2023 Jun 16. Semin Cell Dev Biol. 2024. PMID: 37331841 Review.
-
Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence.Int J Mol Sci. 2023 Mar 28;24(7):6374. doi: 10.3390/ijms24076374. Int J Mol Sci. 2023. PMID: 37047342 Free PMC article. Review.
-
Indian Data on HER2 Fluorescence In Situ Hybridization in Invasive Breast Cancer with Immunohistochemically Equivocal Results As Per 2018 ASCO/CAP Guidelines.South Asian J Cancer. 2022 Aug 23;11(4):281-286. doi: 10.1055/s-0042-1751052. eCollection 2022 Oct. South Asian J Cancer. 2022. PMID: 36756105 Free PMC article.
-
HER2 changes to positive after neoadjuvant chemotherapy in breast cancer: A case report and literature review.World J Clin Cases. 2022 Jan 7;10(1):260-267. doi: 10.12998/wjcc.v10.i1.260. World J Clin Cases. 2022. PMID: 35071526 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous